Does mobilization for autologous stem cell transplantation damage stromal layer formation?

References

• Van Hennik PB, Breems DA, Kusadasi N et al. Stroma-supported progenitor production as a prognostic tool for graft failure following autologous stem cell transplantation. Br J Haematol 2000; 111(2): 674–84.
   PubMed Web of Science ®Google Scholar
• Cashen AF, Lazarus HM, Devine SM. Mobilizing stem cells fromnormal donors: is it possible to improve upon G-CSF? Bone Marrow Transplantation 2007; 39: 577–588.
   Google Scholar
• Klein G. The extracellular matrix of the hematopoietic micro-environment. Experientia Basel 1995; 51: 914–926.
   PubMedGoogle Scholar
• Winkler IG, Léveske JP, Mechanisms of hematopoietic stem cellmobilization: When innate immunity assails that make blood and bone. Exp Hematology 2006; 34: 996–1009.
   PubMed Web of Science ®Google Scholar
• Pappayannopoulou T. Current mechanistic scenarios in hematopoieticstem/progenitor cell mobilization. Blood 2008; 103: 1580–1585.
   Google Scholar
• Ford CD, Greenwood J, Anderson J, Snow G, Petersen FB. CD34+ cell adhesion molecule profiles differ between patients mobilized with granulocyte-colony-stimulating factor alone and chemotherapy followed by granulocyte-colony-stimulating factor. Transfusion 2006; 46(2): 193–198.
   PubMed Web of Science ®Google Scholar
• Papayannopoulou T, Scadden DT. Stem-cell ecology and stem cellin motion. Blood 2008; 111: 3923–3930.
   PubMed Web of Science ®Google Scholar
• Whetton AD, Spooncer E. Role of cytokines and extracellular matrix in the regulation of haemopoietic stem cells. Curr Opin Cell Biol 1998; 10(6): 721–726.
   PubMed Web of Science ®Google Scholar
• Schofield KP, Humphries MJ et al. The effect of alpha4 betal -integrin binding sequences of fibronectin on growth of cells from human hematopoietic progenitors. Blood 1998; 91(9): 3230–3238.
   PubMed Web of Science ®Google Scholar
• Peled A, Kollet O, Ponomaryov T et al. The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5on immature human CD341 cells: role in transendothelial/stromal migrationand engraftment of NOD/SCID mice. Blood 2000; 95(11): 3289–3296.
   PubMed Web of Science ®Google Scholar
• Gu Y-C, Kortesmaa J, Tryggvason K, Persson J, Ekblom P, Jacobsen S-E, Ekblom M. Laminin isoform-specific promotion of adhesion and migration of human bone marrow progenitor cells. Blood 2003; 101(1): 877–885.
   PubMedGoogle Scholar
• Passegué E, Wagers Ai, Giuriato S, Anderson WC, Weissman IL. Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates. The Journal of Experimental Medicine 2005; 202(11): 1599–1611.
   PubMed Web of Science ®Google Scholar
• Metcalf D. Hematopoietic regulators: redundancy or subtlety? Blood 1933; 15: 3515–3523.
   Google Scholar
• Galotto M, Berisso G, Delfino L, Podesta M et al. Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients. Exp Hematol. 1999; 27(9): 1460–1466.
   PubMed Web of Science ®Google Scholar
• Dexter TM, Allen TD, Lajtha LG: Conditions controlling the proliferation on haemopoietic stem cells in vitro. J Cell Physiol 1977; 91:335-344.
   PubMed Web of Science ®Google Scholar
• Gartner S, Kaplan HS. Long-term culture of human bone marrow cells. Proc Natl Acad Sic USA 1980; 77: 4756–4759.
   PubMed Web of Science ®Google Scholar
• Mayer RJ, Davis RB, Schiffer CA et al. Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B. N Engl J Med 1994; 331(14): 896–903.
   PubMed Web of Science ®Google Scholar
• Coiffier B, Lepage E, Briere J et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002; 346(4): 235–242.
   PubMed Web of Science ®Google Scholar
• Steinbach D, Dörffel W, Eggers G et al. Improved results in the treatment of acute myeloid leukemia - Results of study AML-BFM-93 in East Germany with comparisons to the preceding studies AML-I-82 and AML-II-87. Klin Padiatr 2001; 213(4): 162–168.
   PubMed Web of Science ®Google Scholar
• Osby E, Hagberg H, Teerenhovi L et al. CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial. Blood 2003; 10: 3840–3848.
   Google Scholar
• Pfreundschuh M, Trnmper L, Kloess M et al. Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL. Blood 2004; 104: 626–633.
   PubMed Web of Science ®Google Scholar
• Canellos GP, Anderson JR, Propert KJ et al. Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med 1992; 327: 1478–1484.
   PubMed Web of Science ®Google Scholar
• Velasquez WS, Cabanillas F, Salvador P et al. Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP). Blood 1988; 71: 117–122.
   PubMed Web of Science ®Google Scholar
• Moskowitz CH, Bertino JR, Glassman JR et al. Ifosfamide, carboplatin, and etoposide: a highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for trans-plant-eligible patients with non-Hodgkin's lymphoma. J Clin Oncol 1999; 17(12): 3776–3785.
   PubMed Web of Science ®Google Scholar
• Alexian R, Barlogie B, Tucker S. VAD-based regimens as primary treatment for multiple myeloma. Am J Hematol 1990; 33: 86–89.
   PubMed Web of Science ®Google Scholar
• Sutherland R, Anderson L, Keeney M, Rakash N, Chin-Yee I. The ISHAGE Guidelines for CD34 + Cell determination by flow cytometry. Journal of Hematotherapy 1996; 5: 213–226.
   PubMedGoogle Scholar
• Lanza F, Campioni D, Moretti S et al. CD34(+ ) cell subsets and long-term culture colony-forming cells evaluated on both auto-logous and normal bone marrow stroma predict long-term hematopoietic engraftment in patients undergoing autologous peripheral blood stem cell transplantation. Exp Hematol 2001; 29(12): 1484–1493.
   PubMed Web of Science ®Google Scholar
• Lopez-Holgado N, Pata C, Villarón E et al. Long-term bone marrow culture data are the most powerful predictor of peripheral blood progenitor cell mobilization in healthy donors. Haematologica 2005; 90(3): 353–359.
   PubMed Web of Science ®Google Scholar
• Santos AMW, Bitterncourt MA. Cultura de células primordiais de medula ossea tipo Dexter: um procedimento laboratorial que mimetiza a hematopoese. Revista Brasileira de Análises Clinkas 2004; 36: 167–172.
   Google Scholar
• Domenech J, Gihana E, Dayan A et al. Haemopoiesis of transplanted patients with autologous marrows assessed by long-term marrow culture. Br J Haematol 1994; 88(3): 488–496.
   PubMed Web of Science ®Google Scholar
• Tuzuner N, Bennett JM. Reference standards for bone marrow cellularity. Leuk Res 1994; 18: 645–647.
   PubMed Web of Science ®Google Scholar
• Bauermeister DE. Quantitation of bone marrow reticulin-a normal range. Am J Clin Pathol 1971; 56: 24–31.
   PubMed Web of Science ®Google Scholar
• Klein Pi, Moeschberger ML. Survival Analysis: Techniques for Censored and Truncated Data, 1 edn. New York: Springer-Verlag, 1997; 502.
   Google Scholar
• Yeoh JS, Ausema A, Wierenga P, de Haan G, van Os R. Mobilized peripheral blood stem cells provide rapid reconstitution but impaired long-term engraftment in a mouse model. Bone Marrow Transplant 2007; 39(7): 401–409.
   PubMed Web of Science ®Google Scholar
• Hartmann O, Corroller AGL, Blaise D, Michon J, Philip I, Norol F et al. Peripheral blood stem cell and bone marrow transplanta-tion for solid tumors and lymphomas: hematologic recovery and costs: a randomized, controlled trial. Ann Intern Med 1997; 126: 600–607.
   PubMed Web of Science ®Google Scholar
• Schmitz N, Dreger P, Linch DC, Goldstone AH, Boogaerts MA, Demuynck HMS et al. Randomised trial of filgrastimmobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet 1996; 347: 353–357.
   PubMed Web of Science ®Google Scholar
• Beyer J, Schwella N, Zingsem J, Strohscheer I, Schwaner I, Oettle H et al. Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: a randomized comparison. J Clin Oncol 1995; 13: 1328–1335.
   PubMed Web of Science ®Google Scholar
• Sanchez-Guijo FM, Sanchez-Abarca LI, Villaron E et al. Posttransplant hematopoiesis in patients undergoing sibling allogeneic stem cell transplantation reflects that of their respective donors although with a lower functional capability. Exp Hematol 2005; 33(8): 935–943.
   PubMed Web of Science ®Google Scholar
• Selleri C, Maciejewski JP, de Rosa G et al. Long-lasting decrease of marrow and circulating long-term culture initiating cells after allogeneic bone marrow transplant. Bone Marrow Transplant 1999; 23(10): 1029–1037.
   PubMed Web of Science ®Google Scholar
• Ailles LE, Gerhard B and Hogge DE. Detection and Characterization of primitive malignant and normal progenitors in patients with acute myelogenous leukemia using long-term coculture with supportive feeder layers and cytokines. Blood 1997; 90: 2555–2564.
   PubMed Web of Science ®Google Scholar
• Sparrow RL, O'Flaherty E, Blanksby TM, Szer J, van der Weyden MB. Perturbation in the ability of bone marrow stroma from patients with acute myeloid leukemia but not chronic myeloid leukemia to support normal early hematopoietic progenitor cells. Leuk Res 1997; 21(1): 29–36.
   PubMed Web of Science ®Google Scholar
• Visani G, Lemoli RM, Dinota A, Galieni P, Gobbi M, Cavo M, Tura S. Evidence that long-term bone marrow culture of patients with multiple myeloma favors normal hemopoietic proliferation. Transplantation 1989; 48(6): 1026–1031.
   PubMed Web of Science ®Google Scholar
• Bloem AC, Lamme T, Smet M et al. Long-term bone marrow cultured stromal cells regulate myeloma tumour growth in vitro: studies with primary tumour cells and LTBMC-dependent cell lines. Br J Haematol 1998; 100(1): 166–175.
   PubMed Web of Science ®Google Scholar
• Faid L, Van Riet I, de Waele M et al. Adhesive interactions between tumour cells and bone marrow stromal elements in human multiple myeloma. Eur J Haematol 1996; 57(5): 349–358.
   PubMed Web of Science ®Google Scholar
• Knudsen LM, Gaarsdal E, Jensen L, Nielsen KJ, Nikolaisen K, Johnsen HE. Improved priming for mobilization of and optimal timing for harvest of peripheral blood stem cells. J Hematother 1996; 5: 399–406.
   PubMedGoogle Scholar
• Russell NH, McQuaker G, Stainer C, Byrne JL, Haynes AP. Stem cell mobilisation in lymphoproliferative diseases. Bone Marrow Transplant 1998; 22: 935–940.
   PubMed Web of Science ®Google Scholar